• NSC-23766: Precision Rac GTPase Inhibitor for Cell Signaling

  2026-07-13

  NSC-23766 empowers researchers to dissect Rac1-mediated signaling with exceptional specificity, revealing actionable pathways in cancer and immunology. Its selective inhibition profile and robust experimental workflow support advanced applications from apoptosis induction to phagocytosis modulation.

• Resveratrol as a SIRT1 Activator: Optimizing Neuroprotection

  2026-07-13

  Resveratrol’s SIRT1-activating properties enable precise modulation of mitochondrial biogenesis and apoptosis in neurodegeneration models. This article translates high-impact bench findings into robust protocols, troubleshooting tactics, and advanced applications for researchers seeking reliable neuroprotective outcomes.

• Hoechst 33258: Transforming DNA Staining for Tumor Heterogen

  2026-07-12

  This article offers translational researchers a thought-leadership perspective on leveraging Hoechst 33258—a bis-benzimide DNA stain—for advanced cancer biology workflows. Integrating mechanistic insights into tumor heterogeneity, membrane mechanics, and pH regulation, it provides protocol guidance, cross-references recent tumor microenvironment research, and articulates APExBIO’s leadership in reliable DNA staining.

• AM 281 as a CB1 Cannabinoid Receptor Antagonist in TBI Model

  2026-07-10

  AM 281 provides researchers with a potent and selective tool for dissecting CB1 receptor-mediated pathways in models of traumatic brain injury and cognitive dysfunction. Its high affinity and well-defined inverse agonism unlock robust control of endocannabinoid signaling, enabling reproducible workflows and new insights into neuroprotective mechanisms.

• Moxidectin Enhances Polyene Efficacy Against Oral Candidiasi

  2026-07-09

  Recent research demonstrates that moxidectin, a macrocyclic lactone anthelmintic, synergistically enhances the antifungal action of polyenes against Candida albicans by elevating ergosterol biosynthesis. This mechanistic insight supports new combinatorial approaches to oral candidiasis management and highlights the potential for repurposing veterinary antiparasitics in antifungal research.

• D-Lin-MC3-DMA: Gold-Standard Ionizable Liposome for RNA Deli

  2026-07-09

  D-Lin-MC3-DMA is a benchmark ionizable cationic liposome enabling efficient siRNA and mRNA delivery. It offers unmatched hepatic gene silencing potency and supports advanced lipid nanoparticle formulations for therapeutics. Its mechanism ensures high delivery efficiency with reduced toxicity.

• Phosphoenolpyruvate as an Endogenous Inflammation Regulator

  2026-07-08

  This article reviews a groundbreaking study revealing phosphoenolpyruvate (PEP), a glycolytic intermediate, as an intrinsic modulator that inhibits cGAS-STING-driven inflammation and supports healthy aging. The findings establish a direct metabolic-inflammation link and suggest new avenues for metabolic interventions in age-related diseases.

• Indole-3-pyruvic Acid: Optimizing Immune and Plant Bioscienc

  2026-07-08

  Indole-3-pyruvic acid (IPA) is a versatile tool for advancing both plant hormone and immune modulation research. This guide delivers actionable protocols, troubleshooting insights, and cross-domain applications, grounded in recent breakthrough findings for rheumatoid arthritis and auxin biosynthesis.

• Applied Meropenem Workflows in β-Lactam Carbapenem Research

  2026-07-07

  Meropenem from APExBIO empowers researchers to dissect antibacterial mechanisms and optimize Gram-negative and Gram-positive infection models. This article delivers actionable protocols, troubleshooting guidance, and comparative insight for tackling resistance in contemporary β-lactam carbapenem research.

• PERK–JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration

  2026-07-07

  This study delineates how unresolved endoplasmic reticulum stress (ERS) in nucleus pulposus cells promotes pyroptosis and inflammation through PERK-dependent activation of the JAK1–STAT3 pathway. These findings clarify a molecular link in intervertebral disc degeneration (IDD), highlighting potential therapeutic targets for limiting disc cell loss and inflammation.

• Alternariol in Mycotoxin Research: Protocols & Optimization

  2026-07-06

  Alternariol (AOH) is a precision tool for modeling mycotoxin-driven liver fibrosis, apoptosis, and cytochrome P450 metabolism in cellular assays. This guide translates omics-driven evidence into actionable workflows, troubleshooting strategies, and advanced assay design—empowering robust, reproducible experiments.

• 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine:

  2026-07-06

  5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine is a selective α2-adrenergic receptor agonist shown to modulate immune rejection mechanisms in post-surgical osteosarcoma models. Its DMSO solubility and high purity make it a robust tool for receptor signaling research. Recent evidence supports its immune-mediated, rather than cytotoxic, anti-tumor effects.

• Phenylmethanesulfonyl Fluoride (PMSF) in Advanced Protein Ex

  2026-07-05

  Phenylmethanesulfonyl fluoride (PMSF) delivers robust, serine-specific protease inhibition, preserving protein integrity even in challenging sample matrices. By integrating PMSF into extraction and Western blot workflows, researchers can achieve higher fidelity in complex analyses such as recombinant protein purification, with APExBIO providing trusted quality and consistency.

• Recombinant Human Oncostatin M: Precision in Cytokine Resear

  2026-07-04

  Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) from APExBIO enables high-fidelity cytokine stimulation assays, supporting advanced cell proliferation and cytokine release studies. Its exceptional purity, reproducibility, and activity profile streamline experimental workflows and troubleshooting in fibroblast, smooth muscle, and cancer biology research.

• GLP-1 (9-36) Amide in GLP-1 Receptor Signaling Research

  2026-07-03

  GLP-1 (9-36) amide enables precise inhibition of the GLP-1 receptor, empowering investigators to dissect incretin signaling and metabolic regulation in ways not possible with broader-acting agents. This guide translates breakthrough findings and real-world troubleshooting into actionable workflows for advanced metabolic and type 2 diabetes research.

14655 records 1/977 page Next 12345 下5页 Last page